Octahydroisoquinoline compounds as opioid receptor modulators
US7476679B2 · kind B2 · utility
4Cited by
24References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2005 |
| Grant date | Jan 13, 2009 |
| Priority date | — |
| Expiry date | Jun 20, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds which bind to opioid receptors are provided. In a preferred embodiment of the invention, the compounds are opioid receptor antagonists. The present invention also provides methods of treating conditions which are mediated by an opioid receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.